These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32578843)

  • 1. From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.
    Axelrad JE; Malter L; Hong S; Chang S; Bosworth B; Hudesman D
    Inflamm Bowel Dis; 2021 Apr; 27(5):662-666. PubMed ID: 32578843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.
    Törüner M; Kalkan İH; Akyüz F; Tezel A; Çelik AF
    Turk J Gastroenterol; 2021 Jun; 32(6):488-492. PubMed ID: 34405814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
    Brenner EJ; Ungaro RC; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD
    Gastroenterology; 2020 Aug; 159(2):481-491.e3. PubMed ID: 32425234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    Siegel CA; Christensen B; Kornbluth A; Rosh JR; Kappelman MD; Ungaro RC; Johnson DF; Chapman S; Wohl DA; Mantzaris GJ
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S769-S773. PubMed ID: 33085972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    Creemers RH; Rezazadeh Ardabili A; Jonkers DM; Leers MPG; Romberg-Camps MJ; Pierik MJ; van Bodegraven AA
    PLoS One; 2021; 16(10):e0258271. PubMed ID: 34610041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
    Agrawal M; Brenner EJ; Zhang X; Modesto I; Woolcott J; Ungaro RC; Colombel JF; Kappelman MD
    Inflamm Bowel Dis; 2021 Mar; 27(4):585-589. PubMed ID: 33325523
    [No Abstract]   [Full Text] [Related]  

  • 7. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
    Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
    World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden.
    Ludvigsson JF; Axelrad J; Halfvarson J; Khalili H; Larsson E; Lochhead P; Roelstraete B; Simon TG; Söderling J; Olén O
    United European Gastroenterol J; 2021 Mar; 9(2):177-192. PubMed ID: 33704918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
    Sebastian S; Gonzalez HA; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Nov; 14(11):1632-1643. PubMed ID: 32520312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
    Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Derikx LAAP; Lantinga MA; de Jong DJ; van Dop WA; Creemers RH; Römkens TEH; Jansen JM; Mahmmod N; West RL; Tan ACITL; Bodelier AGL; Gorter MHP; Boekema PJ; Halet ERC; Horjus CS; van Dijk MA; Hirdes MMC; Epping Stippel LSM; Jharap B; Lutgens MWMD; Russel MG; Gilissen LPL; Nauta S; van Bodegraven AA; Hoentjen F
    J Crohns Colitis; 2021 Apr; 15(4):529-539. PubMed ID: 33079178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in patients with inflammatory bowel disease.
    Anikhindi SA; Kumar A; Arora A
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
    Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Chela H; Pasha SB; Wan XF; Ghouri YA
    J Gastroenterol Hepatol; 2021 Apr; 36(4):918-926. PubMed ID: 32876952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.
    Mehta SA; Leonard J; Labella P; Cartiera K; Soomro I; Neumann H; Montgomery RA; Ali NM
    Transpl Infect Dis; 2020 Dec; 22(6):e13383. PubMed ID: 32578324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study.
    Attauabi M; Poulsen A; Theede K; Pedersen N; Larsen L; Jess T; Rosager Hansen M; Verner-Andersen MK; V Haderslev K; Berg Lødrup A; Molazahi A; Neumann A; Wase A; Seidelin JB; Burisch J
    J Crohns Colitis; 2021 Apr; 15(4):540-550. PubMed ID: 33035299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease.
    Wetwittayakhlang P; Albader F; Golovics PA; Hahn GD; Bessissow T; Bitton A; Afif W; Wild G; Lakatos PL
    Can J Gastroenterol Hepatol; 2021; 2021():7591141. PubMed ID: 34858891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
    Selim R; Wellens J; Marlow L; Satsangi JJ
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):989. PubMed ID: 34655528
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
    Burke KE; Kochar B; Allegretti JR; Winter RW; Lochhead P; Khalili H; Colizzo FP; Hamilton MJ; Chan WW; Ananthakrishnan AN
    Inflamm Bowel Dis; 2021 Jan; 27(2):155-161. PubMed ID: 33089863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.